Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
AssigneeSociete des Produits Nestle S.A.
InventorPer Torp Sangild
Life of this patent
Estimating the term…
Abstract
The invention discloses a composition comprising LNT and at least another human milk oligosaccharide or precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants and young children.
Claims6
A method of treating or decreasing incidence of growth delay associated with enteral feeding tolerance in an infant or young child in need thereof, the method comprising administering a composition to the infant or young child, the composition comprising lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), 3′ sialyllactose (3-SL), 6′ sialyllactose (6-SL), and 2′-fucosyllactose (2-FL) as the only human milk oligosaccharides in the composition, wherein the composition comprises the LNT and the LNnT in a ratio LNT:LNnT between 5:1 and 1:2.
Dependencies are inferred from the claim text.